Moreover, the direct intratumoral delivery of Moderna’s mRNA-2752 encoding OX40L/IL-23/IL-36γ produced robust anticancer responses in a broad range of tumor microenvironments [39]. This evidence concerns the gene IL36G and neoplasm.